A NEW FRONTIER IN HEART DISEASE: COULD WE ERADICATE CORONARY ARTERY DISEASE?

Summary from the TLDR newsletter

Emerging technologies like artificial intelligence, genetic profiling, and personalized therapies offer a pathway to rethinking how coronary artery disease (CAD) is addressed. Efforts over the past few decades have focused on risk factors like high LDL, smoking, or diabetes as proxies for CAD, but these often sidestep the core issue of atherosclerotic plaque buildup in the arteries. Plaque type, volume, and progress are details that predict heart attack risk more precisely than cholesterol levels alone. New approaches are using imaging enhanced by AI to detect plaque and then implementing gene-slicing techniques to neutralize genetic risks while lifestyle and medications tackle environmental factors. While cost and accessibility pose real questions to scaling these therapies, there is evidence that suggests feasibility.